Stocktoria

Solventum Corp SOLV

NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2024-03-26 · LEI

Solventum Corp statistics & valuation

Market cap$13.8B
P / E8.9×
P / S1.7×
P / B2.7×
Net margin18.7%
Return on equity30.8%
FCF margin-0.1%
Net debt$4.2B
Net debt / EBITDA1.6×
Enterprise value USD$17.9B
EV / EBITDA6.7×
Earnings yield EBIT/EV12.2%
Return on capital19.5%
Graham number -11.1%$75.86

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($75.86); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
16.40% 5.80% 18.70% 202320242025
Gross margin (%)
57.30% 55.60% 53.50% 202320242025
Operating margin (%)
20.60% 12.60% 26.20% 202320242025
Return on equity (%)
11.50% 16.20% 30.80% 202320242025
Shares outstanding
172.7M 173.7M 175.3M 202320242025
Net debt ($)
-$194.0M $7.25B $4.16B 202320242025
Share buybacks ($)
202320242025
Return on assets (%)
9.70% 3.30% 10.90% 202320242025
Free cash flow margin (%)
19.80% 9.80% -0.10% 202320242025
Debt / equity (×)
0.00× 2.71× 1.00× 202320242025
EPS ($)
$7.79 $2.76 $8.88 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Gross margin53.5%55.6%57.3%
Operating margin26.2%12.6%20.6%
Net margin18.7%5.8%16.4%
FCF margin-0.1%9.8%19.8%
Return on assets10.9%3.3%9.7%
Return on equity30.8%16.2%11.5%
Debt / equity1.00×2.71×0.00×
Current ratio1.231.201.46

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.